The Guild has launched a “thought-starter” paper to introduce a major strategic planning project which it says will help secure pharmacy’s future
The paper, called Community Pharmacy 2025 – introduction, foreshadows the project itself, which will shortly see the Guild ask for ideas and feedback.
The Guild points out in the introduction paper that “unlike other commissioned reviews of community pharmacy by government or for government, CP2025 is a project for community pharmacy, their patients and pharmacy staff”.
“CP2025 is being led by the Guild, in partnership with Guild members and with the input of patients, the pharmacist profession and key industry stakeholders.”
The paper says the Guild will put a premium on the opinions and ideas of its members, its professional staff and their patients.
“CP2025 will be informed by qualitative and quantitative market research; various subject matter experts; and the Guild’s industry-leading health economics modelling, as well as our close links with community pharmacy leaders from around the world,” Guild national executive director David Quilty writes in this week’s edition of Forefront.
“A strategic advisory firm with a demonstrated record of working successfully with other ‘transitioning’ sectors will be commissioned to work with the Guild on this project.”
“From this environmental scan, the project will develop a preferred but realistic, working community pharmacy scenario for 2025,” Mr Quilty writes.
“It will then develop a pathway to help transition community pharmacies from where they are today to the working 2025 scenario, by identifying key strategies, actions and outcomes that are likely to be needed to secure the future of community pharmacy to 2025 and beyond.”
The paper points out that CP2025 does not have any predetermined outcomes.
“It will be an open, credible process that looks to find a realistic, preferred direction for community pharmacy in Australia,” it says.
The project will take into account various factors including the overall state of the Australian economy and its influence on community pharmacies’ fortunes; expected growth in the health sector and the ageing population; the pipeline of new medicines including biologics and biosimilars; and broadening the scope of pharmacy practice.
The fact that community pharmacies operated in the retail space will also be recognised.